- Home
- CLOV vs QQQX Comparison
CLOV vs QQQX Comparison
Compare CLOV & QQQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLOV | QQQX |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLOV | QQQX |
|---|---|---|
| Price | $2.69 | $30.55 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.90 | N/A |
| AVG Volume (30 Days) | ★ 5.1M | 98.6K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.03% |
| EPS Growth | ★ 38.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,924,308,000.00 | N/A |
| Revenue This Year | $52.59 | N/A |
| Revenue Next Year | $15.37 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.34 | N/A |
| 52 Week Low | $1.58 | $24.13 |
| 52 Week High | $3.92 | $30.40 |
Technical Indicators
Market Signals| Indicator | CLOV | QQQX |
|---|---|---|
| Relative Strength Index (RSI) | 71.17 | 71.21 |
| Support Level | $2.51 | $27.08 |
| Resistance Level | $2.81 | N/A |
| Average True Range (ATR) | 0.13 | 0.34 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 86.79 | 99.25 |
Price Performance
Historical ComparisonAbout CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the S&P 500 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets (as defined below) in a diversified equity portfolio made up of securities comprising the S&P 500 Index (or securities that have economic characteristics that are similar to those securities comprising the S&P 500 Index) that seeks to substantially replicate price movements of the S&P 500 Index and is designed to support the Fund's option strategy.